Postinfluenza A(H3N2) refractory invasive pulmonary aspergillosis

J Formos Med Assoc. 2017 May;116(5):404-405. doi: 10.1016/j.jfma.2016.08.005. Epub 2016 Oct 7.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antiviral Agents / administration & dosage
  • Bronchoalveolar Lavage Fluid / microbiology
  • Disease Management
  • Disease Progression
  • Fatal Outcome
  • Hemopneumothorax* / diagnosis
  • Hemopneumothorax* / etiology
  • Hemopneumothorax* / surgery
  • Humans
  • Influenza A Virus, H3N2 Subtype / isolation & purification
  • Influenza, Human / complications*
  • Influenza, Human / virology
  • Invasive Pulmonary Aspergillosis* / diagnosis
  • Invasive Pulmonary Aspergillosis* / etiology
  • Invasive Pulmonary Aspergillosis* / physiopathology
  • Lung / diagnostic imaging*
  • Male
  • Nasopharynx / microbiology*
  • Oseltamivir / administration & dosage*
  • Radiography / methods
  • Shock, Septic / diagnosis
  • Shock, Septic / etiology
  • Shock, Septic / therapy
  • Thoracentesis / methods

Substances

  • Antiviral Agents
  • Oseltamivir